company predictions, page-8

The "Protect Mum and Dad Investor Club" should also look out for those who keep posting over and over again about the same thing, pushing their one point down the throats of others, yet rates the share as a BUY. It swings both ways, everyone is allowed to put forth their opinion and not get drowned out by repetitive posts saying the same things until someone gets worn out and gives up.

Investing in Biotechs is high risk, high reward. Nothing ever goes the way investors or even management would like. Partnerships break down or are never even found, the drug/product never really cuts through the existing standard of care or current market share owner, the company runs out of money, years are added due to additional trials or no approval ever given, the list goes on and on.

But the biggest thing for most Biotech investors is that a majority of drugs/inovations never make it to market, for an investor to ride through trials etc and still be standing and not get bucked off due to things not going according to plan is rare imo. Good luck to those hanging in there, it's a tough game for anyone to be a part of.